The objective of this IAA is to provide a broad range of preclinical developmental resources to bring new therapies and preventive measures for biodefense and emerging diseases from the laboratory to efficacy testing in non-human primates.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$1,036,210
Indirect Cost
City
State
Country
United States
Zip Code